Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008

Journal of Infection

Volumn 65, Issue 5, 2012, Pages 392-399

  Liao, Chun Hsing ^a   Chuang, Chia Yunn ^b   Huang, Yu Tsung ^a,b   Lee, Ping Ing ^b   Hsueh, Po Ren ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bacteremia; Campylobacter species; Fluoroquinolone resistance; Macrolide resistance; Taiwan

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ARGININE; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DORIPENEM; ERYTHROMYCIN; GEMIFLOXACIN; GLUTAMINE; IMIPENEM; ISOLEUCINE; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; NEMONOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 16S; SULTAMICILLIN; THREONINE;

ABDOMINAL INFECTION; ABDOMINAL SURGERY; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ASP GENE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATE; CADF GENE; CAMPYLOBACTER COLI; CAMPYLOBACTER FETUS; CAMPYLOBACTER JEJUNI; CAUSE OF DEATH; CELLULITIS; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE SEQUENCE; GYRA GENE; HIPO GENE; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATOR GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; PRIMARY INFECTION; SCHOOL CHILD; SEPTIC SHOCK; SYNDROME DELINEATION; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; GENES, BACTERIAL; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84867333090     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.06.014     Document Type: Article

References (28)

1. Blaser M.J., Berkowitz I.D., LaForce F.M., Cravens J., Reller L.B., Wang W.L. Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med 1979, 91:179-185.
2. Drake A.A., Gilchrist M.J., Washington J.A., Huizenga K.A., Van Scoy R.E. Diarrhea due to Campylobacter fetus subspecies jejuni. A clinical review of 63 cases. Mayo Clin Proc 1981, 56:414-423.
3. Feodoroff B., Lauhio A., Ellström P., Rautelin H. A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility. Clin Infect Dis 2011, 53:e99-106.
4. Fernández-Cruz A., Muñoz P., Mohedano R., Valerio M., Marín M., Alcalá L., et al. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore) 2010, 89:319-330.
5. Gazaigne L., Legrand P., Renaud B., Bourra B., Taillandier E., Brun-Buisson C., et al. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis 2008, 27:185-189.
6. Lu P.L., Hsueh P.R., Hung C.C., Chang S.C., Luh K.T., Lee C.Y. Bacteraemia due to Campylobacter species: high rate of resistance to macrolide and quinolone antibiotics. J Formos Med Assoc 2000, 99:612-617.
7. Nielsen H., Hansen K.K., Gradel K.O., Kristensen B., Ejlertsen T., Østergaard C., et al. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect 2010, 16:57-61.
8. Pacanowski J., Lalande V., Lacombe K., Boudraa C., Lesprit P., Legrand P., et al. Campylobacter bacteraemia: clinical features and factors associated with fatal outcome. Clin Infect Dis 2008, 47:790-796.
9. Pigrau C., Bartolome R., Almirante B., Planes A.M., Gavalda J., Pahissa A. Bacteraemia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 1997, 25:1414-1420.
10. Tee W., Mijch A. Campylobacter jejuni bacteraemia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis 1998, 26:91-96.
11. Man S.M. The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol 2011, 8:669-685.
12. Engberg J., Aarestrup F.M., Taylor D.E., Gerner-Smidt P., Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001, 7:24-34.
13. Gaunt P.N., Piddock L.J. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J Antimicrob Chemother 1996, 37:747-757.
14. Engberg J., Neimann J., Nielsen E.M., Aerestrup F.M., Fussing V. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis 2004, 10:1056-1063.
15. Nelson J.M., Smith K.E., Vugia D.J., Rabatsky-Ehr T., Segler S.D., Kassenborg H.D., et al. Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter infection. J Infect Dis 2004, 190:1150-1157.
16. Evans M.R., Northey G., Sarvotham T.S., Rigby C.J., Hopkins A.L., Thomas D.R. Short-term and medium-term clinical outcomes of quinolone-resistant Campylobacter infection. Clin Infect Dis 2009, 48:1500-1506.
17. Chow J.W., Fine M.J., Shlaes D.M., Quinn J.P., Hooper D.C., Johnson M.P., et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991, 115:585-590.
18. Al Amri A., Senok A.C., Ismaeel A.Y., Al-Mahmeed A.E., Botta G.A. Multiplex PCR for direct identification of Campylobacter spp. in human and chicken stools. J Med Microbiol 2007, 56:1350-1355.
19. Gorkiewicz G., Feierl G., Schober C., Dieber F., Köfer J., Zechner R., et al. Species-specific identification of campylobacters by partial 16S rRNA gene sequencing. J Clin Microbiol 2003, 41:2537-2546.
20. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement 2012, CLSI Document M100-S22, CLSI, Wayne, PA.
21. Luangtongkum T., Morishita T.Y., El-Tayeb A.B., Ison A.J., Zhang Q. Comparison of antimicrobial susceptibility testing of Campylobacter spp. by the agar dilution and the agar disk diffusion methods. J Clin Microbiol 2007, 45:590-594.
22. Andrews J.M., BSAC Working Party on Susceptibility Testing BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009, 64:454-489.
23. Kim H.B., Park C.H., Kim C.J., Kim E.C., Jacoby G.A., Hooper D.C. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 2009, 53:639-645.
24. Penner J.L. The genus Campylobacter: a decade of progress. Clin Microbiol Rev 1988, 1:157-172.
25. Lachance N., Gaudreau C., Lamothe F., Larivière L.A. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother 1991, 35(5):813-818.
26. Wang S.C., Chang L.Y., Hsueh P.R., Lu C.Y., Lee P.I., Shao P.L., et al. Campylobacter enteritis in children in northern Taiwan-a 7-year experience. J Microbiol Immunol Infect 2008, 41:408-413.
27. Lehtopolku M., Kotilainen P., Puukka P., Nakari U.M., Siitonen A., Eerola E., et al. Inaccuracy of the disk diffusion method compared with the agar dilution method for susceptibility testing of Campylobacter spp. J Clin Microbiol 2012, 50:52-56.
28. Yang J.C., Lee P.I., Hsueh P.R. In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. Eur J Clin Microbiol Infect Dis 2010, 29:1369-1375.